30/11/2022 Eisai presents full results from the Clarity AD Phase III trial of lecanemab Science watch
30/11/2022 Eli Lilly presents top-line results of its Phase III TRAILBLAZER-ALZ 4 study Science watch
30/11/2022 Roche discontinues clinical trials of gantenerumab, after GRADUATE studies fail to meet their primary endpoints Science watch
23/11/2022 New study finds that amyloid-PET diagnostic tests may help improve long-term outcomes for patients with Alzheimer’s disease Science watch
14/11/2022 New article on empowerment published in the Journal of Advanced Nursing, co-authored by Alzheimer Europe Science watch
30/10/2022 New literature review evaluates existing resilience measures used for dementia research Science watch
10/10/2022 AB Science receives first authorisations to initiate its Phase III study with masitinib for AD Science watch
09/10/2022 New paper "European consensus for the diagnosis of MCI and mild dementia: Preparatory phase" co-authored by Alzheimer Europe is published in journal Alzheimer's & Dementia Science watch
07/10/2022 The risk of suicide is twice as high among individuals who have recently received a dementia diagnosis compared to those without the condition Science watch
